Paige Mahaney
Chief Scientific Officer · C4 Therapeutics, Inc.
Individual
- 2024
- Feb 18, 2026
- 3
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Paige Mahaney files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Leonard Reyno - $22K in CCCC purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Paige Mahaney?
Paige Mahaney is a corporate insider, tracked as Chief Scientific Officer of C4 Therapeutics, Inc. (CCCC). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Paige Mahaney last file a Form 4?
The most recent primary Form 4 on record is dated 18 February 2026, one of 3 filings going back to 2024.
